Bigtex
VIP Member
- Aug 14, 2012
- 2,096
- 3,419
Probably you tested too soon. The 1/2 life of a RBC is about 120 days so it may take 3-4 months to get things back to normal. Be very careful doing those blood dumps and check your ferritin levels. Research has show that 35% of people who regularly dump blood cause an iron deficiency anemia. It can also have an effect on your training,. Maximal power output, VO2 max, and hemoglobin mass have been shown to decreased up to four weeks after a single whole blood donation in moderately trained people. Remember, no randomized or prospective studies have observed a direct relation between the testosterone induced secondary erythrocytosis and thromboembolic events.I was using cream and I think that was what elevated my levels a few weeks ago. Then completely stopped for a few weeks did another test and RBC count went to normal but the HCT still high
In a study done over a two-year period of time they looked at men who donated blood that were on testosterone therapy and at least 25% of them had a hematocrit above
54% and when they came back for repeat donations 44% of them had a persistent elevation of hematocrit above 54%. So it essentially showed that repeat donations were insufficient to maintain a hematocrit below 54% in many men.
Since I realized you are a woman, the normal range is <48. The high is 2 points less than a man (50). Also remember, experts have already admitted this high number was just pulled out of thin air. There is no evidence that having high HCT (secondary erythrocytosis) is going to cause a thromboembolic event. There are over 80 million people that live higher than 2,500 meters and they develop a secondary erythrocytosis. Men in parts of Bolivia for instance have a normal range of HCT from 45-61%. These men are not at an increased risk of thrombotic events nor do they have to undergo phlebotomies to manage their hematocrit.
Good video
How different esters typically effect erythrocytosis
Henok Tadesse Ayele, Vanessa C. Brunetti, Christel Renoux, Vicky Tagalakis, Kristian B. Filion, Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials. Thrombosis Research. Volume 199, 2021, Pages 123-131, ISSN 0049-3848,
https://doi.org/10.1016/j.thromres.2020.12.029.
Conclusions
Our systematic review suggests that TRT is not associated with an increased risk of VTE. However, estimates were accompanied by a wide 95% CIs, and a clinically important increased risk cannot be ruled out.https://www.sciencedirect.com/science/a ... 4821000062
We found no evidence of an increased risk of VTE with testosterone use.